In a win for Upside Foods (and chickens), the Berkeley, California-based company received a nod from the U.S. Food and Drug Administration (FDA) for its cultivated meat. The recently announced decision makes Upside Foods’ cell-based product the first in its category to complete the FDA’s pre-market consultation for human food made using animal cell culture technology.
In a statement released on November 16, 2022, the FDA revealed that after evaluating the information submitted by Upside Foods, there are “no further questions” about the product’s safety. This is not, however, an approval process. In addition to meeting the FDA’s requirements, including facility registration for the cell culture portion, the startup’s manufacturing facilities will need a grant of inspection from the Department of Agriculture Food Safety and Inspection Service (USDA-FSIS).
Additionally,…
